HIV-CAUSAL, Collaboration (2012). Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countries. Clinical infectious diseases, 54(9), pp. 1364-72. Cary, N.C.: Oxford University Press 10.1093/cid/cis203
|
Text
cis203.pdf - Published Version Available under License Publisher holds Copyright. Download (261kB) | Preview |
The lower tuberculosis incidence reported in human immunodeficiency virus (HIV)-positive individuals receiving combined antiretroviral therapy (cART) is difficult to interpret causally. Furthermore, the role of unmasking immune reconstitution inflammatory syndrome (IRIS) is unclear. We aim to estimate the effect of cART on tuberculosis incidence in HIV-positive individuals in high-income countries.
Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Paediatric Medicine |
UniBE Contributor: |
Aebi, Christoph |
ISSN: |
1058-4838 |
Publisher: |
Oxford University Press |
Language: |
English |
Submitter: |
Anette van Dorland |
Date Deposited: |
04 Oct 2013 14:37 |
Last Modified: |
05 Dec 2022 14:11 |
Publisher DOI: |
10.1093/cid/cis203 |
PubMed ID: |
22460971 |
Web of Science ID: |
000302805700024 |
Additional Information: |
HIV-CAUSAL Collaboration;R01-AI073127/AI/NIAID NIH HHS/;U10-AA013566/AA/NIAAA NIH HHS/;Clin Infect Dis. 2012 May;54(9):1364-72. doi: 10.1093/cid/cis203. Epub 2012 Mar 28. |
BORIS DOI: |
10.48350/14953 |
URI: |
https://boris.unibe.ch/id/eprint/14953 (FactScience: 222096) |
Actions (login required)
 |
Edit item |